| 000600 (2015) |
Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. |
| 000F07 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao | A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. |
| 000F44 (2010) |
J. Theo M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Pays-Bas, Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
| 001496 (2006) |
Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. Seong | Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. |
| 000264 (2017) |
Nicholas Wohlgemuth [États-Unis] ; Yang Ye [États-Unis] ; Katherine J. Fenstermacher [États-Unis] ; Hsuan Liu [États-Unis] ; Andrew P. Lane [États-Unis] ; Andrew Pekosz [États-Unis] | The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. |
| 000741 (2014) |
Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis] | Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model |
| 001132 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. |
| 001225 (2008) |
Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky | Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). |
| 002D79 (????) |
Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov | [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice]. |
| 000449 (2016) |
J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie] | H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. |
| 000533 (2015) |
Larisa Rudenko [Russie] ; Irina Isakova-Sivak | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. |
| 000563 (2015) |
Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. |
| 000A76 (2012) |
Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. Rudenko | Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). |
| 000A85 (2012) |
Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao | An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults |
| 002D78 (????) |
Iu A. Desheva ; G V Danini ; E P Grigor'Eva ; S A Donina ; I V Kiseleva ; A R Rekstin ; L A Ermakova ; V K Natsina ; V M Nikolaeva ; N I Lonskaia ; G A El'Shina ; V G Zhavoronkov ; V P Drinevski ; M K Erofeeva ; A N Na Khin ; L G Rudenko | [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. |
| 002D80 (????) |
E Iu Boravleva ; N F Lomakina ; E A Kropotkina ; I A Rudneva ; S S Iamnikova ; L G Rudenko ; V V Drygin ; A S Gambarian | [The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2]. |
| 002D95 (????) |
A R Rekstin ; K. Lu ; D. Kats ; L G Rudenko | [Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses]. |
| 002E10 (????) |
S G Markushin ; Iu Z. Gendon ; G G Krivtsov ; I I Akopova ; A S Sukhno ; A D Pereverzev | [Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant]. |
| 002E24 (????) |
I V Kiseleva ; A I Klimov ; E P Grigor'Eva ; N V Larionova ; G I Aleksandrova ; L G Rudenko | [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. |
| 002E38 (????) |
O S Kashirina ; M I Chernikova ; Yu M. Vasiliev | [COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA]. |
| 000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
| 000566 (2015) |
Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Amanda Balish [États-Unis] ; Joyce Jones [États-Unis] ; Sharmi Thor [États-Unis] ; Charles Todd Davis [États-Unis] ; Melissa Pearce [États-Unis] ; Terrence Tumpey [États-Unis] ; David Cureton [États-Unis] ; Li-Mei Chen [États-Unis] ; Julie Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis] | Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation. |
| 000B91 (2011) |
I V Kiseleva ; J T M. Voeten ; L C P. Teley ; N V Larionova ; I A Dubrovina ; Zh A. Berdygulova ; E A Bazhenova ; H. Van Den Bosch ; J G M. Heldens ; L G Rudenko | [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. |
| 000C35 (2011) |
T V Chirkova [Russie] ; A N Naykhin ; G D Petukhova ; D A Korenkov ; S A Donina ; A N Mironov ; L G Rudenko | Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. |
| 000C50 (2011) |
Penghui Yang [République populaire de Chine] ; Yueqiang Duan ; Cheng Wang ; Li Xing ; Xiao Gao ; Chong Tang ; Deyan Luo ; Zhongpeng Zhao ; Weihong Jia ; Daxin Peng ; Xiufan Liu ; Xiliang Wang | Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. |
| 001252 (2008) |
Joo Sub Lee [Corée du Sud] ; Hyun Soo Kim ; Sang Heui Seo | Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine. |
| 001283 (2008) |
Tomy Joseph [États-Unis] ; Josephine Mcauliffe ; Bin Lu ; Leatrice Vogel ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao | A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. |
| 001476 (2006) |
Amorsolo L. Suguitan [États-Unis] ; Josephine Mcauliffe [États-Unis] ; Kimberly L. Mills [États-Unis] ; Hong Jin [États-Unis] ; Greg Duke [États-Unis] ; Bin Lu [États-Unis] ; Catherine J. Luke [États-Unis] ; Brian Murphy [États-Unis] ; David E. Swayne [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets |
| 001790 (2002) |
W. E. P. Beyer [Pays-Bas] ; A. M. Palache [Pays-Bas] ; J. C. De Jong [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas] | Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis |
| 001C00 (1996) |
H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. Isegawa | The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region. |
| 002B01 (1976) |
J M Gwaltney | The use of live attenuated influenza vaccine ts-1(E) in man. |
| 002D84 (????) |
E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko | [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. |
| 002D90 (????) |
F I Polezhaev ; G N Budilovski ; L M Garmashova ; Iu R. Rome Ko-Gurko ; A Iu Egorov | [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)]. |
| 002D91 (????) |
I V Kiseleva ; N V Larionova ; L C P. Teley ; L G Rudenko | [Restriction analysis of genome composition of live influenza vaccine]. |
| 002E00 (????) |
Iu Z. Gendon ; S G Markushin ; T M Tsfasman ; I I Akopova ; N K Akhmatova ; I B Koptiaeva | [New cold-adapted donor strains for live influenza vaccine]. |
| 002E06 (????) |
I V Kiseleva ; N V Larionova ; J T M. Voeten ; L C P. Teley ; S K M. Drieszen-Van Der Cruijsen ; J G M. Heldens ; J F Van Den Bosch ; L G Rudenko | [Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine]. |
| 002E11 (????) |
L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova | [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A]. |
| 000318 (2017) |
Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis] | Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice |
| 000406 (2016) |
Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. Weiss | Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses. |
| 000531 (2015) |
Milton Thomas [États-Unis] ; Zhao Wang [États-Unis] ; Chithra C. Sreenivasan [États-Unis] ; Ben M. Hause [États-Unis] ; Gourapura J Renukaradhya [États-Unis] ; Feng Li [États-Unis] ; David H. Francis [États-Unis] ; Radhey S. Kaushik [États-Unis] ; Mahesh Khatri [États-Unis] | Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs. |
| 000550 (2015) |
José Vicente Pérez-Gir N ; Sergio G Mez-Medina ; Anja Lüdtke ; Cesar Munoz-Fontela [Allemagne] | Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. |
| 000577 (2015) |
Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie] | Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. |
| 000602 (2015) |
Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets. |
| 000682 (2014) |
Svetlana V. Shcherbik [États-Unis] ; Nicholas C. Pearce [États-Unis] ; Marnie L. Levine [États-Unis] ; Alexander I. Klimov [États-Unis] ; Julie M. Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis] | Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines. |
| 000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
| 000730 (2014) |
Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie] | Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus |
| 000864 (2013) |
Wen He [République populaire de Chine] ; Wei Wang ; Huamin Han ; Lei Wang ; Ge Zhang ; Bin Gao | Molecular basis of live-attenuated influenza virus. |
| 000A23 (2012) |
Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen ; Jing Guo ; Ying Zhang ; Guohua Deng ; Yuelong Shu ; Dayan Wang ; Yongping Jiang ; Yoshihiro Kawaoka [États-Unis] ; Zhigao Bu ; Hualan Chen | Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice. |
| 000C38 (2011) |
Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry Bushmenkov | Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. |
| 000C81 (2011) |
Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. Katz | Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. |
| 000C86 (2011) |
Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing Xu | Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine |
| 000D08 (2011) |
Gary J. Nabel [États-Unis] ; Chih-Jen Wei [États-Unis] ; Julie E. Ledgerwood [États-Unis] | Vaccinate for the next H2N2 pandemic now |
| 000E67 (2010) |
Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. Nabel | Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. |
| 000E85 (2010) |
Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio Ledesma | Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. |
| 001023 (2009) |
Jeff Alexander [États-Unis] ; Pamuk Bilsel [États-Unis] ; Marie-France Del Guercio [États-Unis] ; Stephani Stewart [États-Unis] ; Aleksandra Marinkovic-Petrovic [États-Unis] ; Scott Southwood [États-Unis] ; Claire Crimi [États-Unis] ; Lo Vang [États-Unis] ; Les Walker [États-Unis] ; Glenn Ishioka [États-Unis] ; Vivek Chitnis [États-Unis] ; Alessandro Sette [États-Unis] ; Erika Assarsson [États-Unis] ; Drew Hannaman [États-Unis] ; Jason Botten [États-Unis] ; Mark J. Newman [États-Unis] | Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice |
| 001062 (2009) |
Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie] | Pandemic Vaccine Preparedness—Have We Left Something Behind? |
| 001087 (2009) |
Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan Chen | Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. |
| 001569 (2006) |
J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis] | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential |
| 001653 (2004) |
Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima Youil | Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants. |
| 001660 (2004) |
N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. Saenger | Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. |
| 001872 (2001) |
M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie] | Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice |
| 001B22 (1997) |
K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate | [Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers]. |
| 002137 (1989) |
M L Clements [États-Unis] ; S D Sears ; K. Christina ; B R Murphy ; M H Snyder | Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors. |
| 002348 (1986) |
G. I. Alexandrova [Russie] ; G. N. Budilovsky [Russie] ; T. A. Koval [Russie] ; F. I. Polezhaev [Russie] ; L. M. Garmashova [Russie] ; Yu. Z. Ghendon [Russie] ; Y. R. Romanova [Russie] ; A. A. Smorodintsev [Russie] | Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial |
| 002D75 (????) |
T E Medvedeva ; Iu R. Romanova ; M I Gushchina ; L G Rudenko ; Iu Z. Gendon ; G I Aleksandrova ; A I Klimov | [The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. |
| 002D88 (????) |
Iu A. Desheva ; T A Smolonogina ; M V Sergeeva ; A R Rekstin ; D. Swayne ; A I Klimov ; L G Rudenko | [Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. |
| 002D97 (????) |
I V Kiseleva ; E A Bazhenova ; N V Larionova ; E A Fedorova ; I A Dubrovina ; I N Isakova-Sivak ; L G Rudenko | [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine]. |
| 002E26 (????) |
T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko | [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype]. |
| 002E39 (????) |
S G Markushin ; T M Tsfasman ; A V Terekhov ; K V Lisovskaya ; I I Akopova | [COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES]. |
| 002E48 (????) |
H F Maassab [États-Unis] ; M L Bryant | The development of live attenuated cold-adapted influenza virus vaccine for humans. |
| 000176 (2018) |
Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines |
| 000420 (2016) |
Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde] | Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses. |
| 000497 (2015) |
E Y Boravleva ; I A Chvala ; N F Lomakina ; P I Repin ; N S Mudrak ; L G Rudenko ; A S Gambaryan ; V V Drygin | [Testing of apathogenic influenza virus H5N3 as a poultry live vaccine]. |
| 000505 (2015) |
Sarder Mohammed Asaduzzaman [Canada] ; Junling Ma [Canada] ; P. Van Den Driessche [Canada] | The coexistence or replacement of two subtypes of influenza. |
| 000556 (2015) |
Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine] | Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge. |
| 000561 (2015) |
Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
| 000607 (2015) |
José Esteban Mu Oz-Medina [Mexique] ; Carlos Javier Sánchez-Vallejo [Mexique] ; Alfonso Méndez-Tenorio [Mexique] ; Irma Eloísa Monroy-Mu Oz [Mexique] ; Javier Angeles-Martínez [Mexique] ; Andrea Santos Coy-Arechavaleta [Mexique] ; Clara Esperanza Santacruz-Tinoco [Mexique] ; Joaquín González-Ibarra [Mexique] ; Yu-Mei Anguiano-Hernández [Mexique] ; César Raúl González-Bonilla [Mexique] ; Eva Ram N-Gallegos [Mexique] ; José Alberto Díaz-Qui Onez [Mexique] | In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential |
| 000652 (2014) |
Christopher D. O'Donnell [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. |
| 000724 (2014) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets |
| 000747 (2014) |
Svetlana Shcherbik [États-Unis] ; Sheila B. Sergent ; William G. Davis ; Bo Shu ; John Barnes ; Irina Kiseleva ; Natalie Larionova ; Alexander Klimov ; Tatiana Bousse | Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. |
| 000865 (2013) |
Manojkumar Ramanunninair [États-Unis] ; Jianhua Le [États-Unis] ; Shiroh Onodera [États-Unis] ; Andrew A. Fulvini [États-Unis] ; Barbara A. Pokorny [États-Unis] ; Jeanmarie Silverman [États-Unis] ; Rene Devis [États-Unis] ; Jennifer M. Arroyo [États-Unis] ; Yu He [États-Unis] ; Alex Boyne [États-Unis] ; Jayati Bera [États-Unis] ; Rebecca Halpin [États-Unis] ; Erin Hine [États-Unis] ; David J. Spiro [États-Unis] ; Doris Bucher [États-Unis] | Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds |
| 000A27 (2012) |
Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo Icardi | Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. |
| 000A50 (2012) |
Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto Burioni | Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines |
| 000B97 (2011) |
Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. Osterhaus | Vaccination strategies to protect children against seasonal and pandemic influenza. |
| 000C34 (2011) |
Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine] | Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A |
| 000C60 (2011) |
Irina Isakova-Sivak [États-Unis] ; Li-Mei Chen ; Yumiko Matsuoka ; J Theo M. Voeten ; Irina Kiseleva ; Jacco G M. Heldens ; Han Van Den Bosch ; Alexander Klimov ; Larisa Rudenko ; Nancy J. Cox ; Ruben O. Donis | Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). |
| 000F05 (2010) |
Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿ |
| 001030 (2009) |
Amorsolo L. Suguitan ; Michael P. Marino ; Purvi D. Desai ; Li-Mei Chen ; Yumiko Matsuoka ; Ruben O. Donis ; Hong Jin ; David E. Swayne ; George Kemble ; Kanta Subbarao | The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus |
| 001060 (2009) |
Lauren J. Dimenna [États-Unis] ; Hildegund C J. Ertl | Pandemic influenza vaccines. |
| 001081 (2009) |
Terho Heikkinen ; Ville Peltola | Influenza vaccination of children. |
| 001213 (2008) |
Werner Lange | [Pandemic scenarios]. |
| 001240 (2008) |
William Paul Glezen [États-Unis] | Modifying clinical practices to manage influenza in children effectively. |
| 001243 (2008) |
R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R Eggers | Influenza guideline for South Africa--update 2008. |
| 001482 (2006) |
Edwin D. Kilbourne [États-Unis] | Influenza Pandemics of the 20th Century |
| 001492 (2006) |
Monika Lindemann [Allemagne] ; Oliver Witzke ; Peter Lütkes ; Melanie Fiedler ; Ernst Kreuzfelder ; Thomas Philipp ; Michael Roggendorf ; Hans Grosse-Wilde | ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. |
| 001587 (2005) |
Rajan Patel [États-Unis] ; Ira M. Longini ; M Elizabeth Halloran | Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. |
| 001737 (2003) |
H. Chen [États-Unis] ; Y. Matsuoka [États-Unis] ; David Swayne [États-Unis] ; Q. Chen [États-Unis] ; N. J. Cox [États-Unis] ; B. R. Murphy [États-Unis] ; K. Subbarao [États-Unis] | Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate |
| 001745 (2002) |
Jason R. Williams [États-Unis] ; Po-Yen Chen ; Cheng T. Cho ; Tom D Y. Chin | Influenza: prospect for prevention and control. |
| 001E53 (1993) |
T E Medvedeva ; V K Kudriavtseva ; G N Nevedomskaia ; I V Zhikhareva ; M I Gushchina ; F N Zolotarev ; G M Vode Ko ; K V Lisovskaia ; V V Iotov ; M I Kha Der | [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine]. |
| 001E68 (1993) |
Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis] | Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge |
